ALVOTECH SA (ALVO) Fundamental Analysis & Valuation

NASDAQ:ALVO • LU2458332611

Current stock price

3.435 USD
+0.15 (+4.41%)
Last:

This ALVO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALVO Profitability Analysis

1.1 Basic Checks

  • ALVO had positive earnings in the past year.
  • ALVO had a negative operating cash flow in the past year.
  • ALVO had negative earnings in 4 of the past 5 years.
  • In the past 5 years ALVO always reported negative operating cash flow.
ALVO Yearly Net Income VS EBIT VS OCF VS FCFALVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • With an excellent Return On Assets value of 1.88%, ALVO belongs to the best of the industry, outperforming 88.01% of the companies in the same industry.
  • The Return On Invested Capital of ALVO (5.22%) is better than 90.52% of its industry peers.
Industry RankSector Rank
ROA 1.88%
ROE N/A
ROIC 5.22%
ROA(3y)-25.06%
ROA(5y)-30.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALVO Yearly ROA, ROE, ROICALVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 -50

1.3 Margins

  • With an excellent Profit Margin value of 4.74%, ALVO belongs to the best of the industry, outperforming 88.97% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 13.28%, ALVO belongs to the top of the industry, outperforming 91.30% of the companies in the same industry.
  • With a decent Gross Margin value of 60.00%, ALVO is doing good in the industry, outperforming 77.18% of the companies in the same industry.
  • ALVO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.28%
PM (TTM) 4.74%
GM 60%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y34.59%
GM growth 5YN/A
ALVO Yearly Profit, Operating, Gross MarginsALVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ALVO Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALVO is destroying value.
  • ALVO has more shares outstanding than it did 1 year ago.
  • ALVO has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ALVO has remained at the same level compared to a year ago.
ALVO Yearly Shares OutstandingALVO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
ALVO Yearly Total Debt VS Total AssetsALVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • ALVO has an Altman-Z score of -1.12. This is a bad value and indicates that ALVO is not financially healthy and even has some risk of bankruptcy.
  • ALVO's Altman-Z score of -1.12 is in line compared to the rest of the industry. ALVO outperforms 54.93% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACC0.87
WACC6.03%
ALVO Yearly LT Debt VS Equity VS FCFALVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

2.3 Liquidity

  • A Current Ratio of 1.89 indicates that ALVO should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.89, ALVO is not doing good in the industry: 77.76% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.16 indicates that ALVO should not have too much problems paying its short term obligations.
  • The Quick ratio of ALVO (1.16) is worse than 83.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.16
ALVO Yearly Current Assets VS Current LiabilitesALVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ALVO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 108.05% over the past year.
  • ALVO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.70%.
  • Measured over the past years, ALVO shows a very strong growth in Revenue. The Revenue has been growing by 53.35% on average per year.
EPS 1Y (TTM)108.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.17%
Revenue 1Y (TTM)19.7%
Revenue growth 3Y90.62%
Revenue growth 5Y53.35%
Sales Q2Q%10.14%

3.2 Future

  • ALVO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 222.21% yearly.
  • Based on estimates for the next years, ALVO will show a very strong growth in Revenue. The Revenue will grow by 25.37% on average per year.
EPS Next Y493.79%
EPS Next 2Y222.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year37.22%
Revenue Next 2Y31.38%
Revenue Next 3YN/A
Revenue Next 5Y25.37%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALVO Yearly Revenue VS EstimatesALVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 500M 1B 1.5B
ALVO Yearly EPS VS EstimatesALVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

6

4. ALVO Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 49.07, the valuation of ALVO can be described as expensive.
  • Based on the Price/Earnings ratio, ALVO is valued cheaper than 90.14% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ALVO to the average of the S&P500 Index (24.75), we can say ALVO is valued expensively.
  • The Price/Forward Earnings ratio is 8.26, which indicates a very decent valuation of ALVO.
  • Based on the Price/Forward Earnings ratio, ALVO is valued cheaper than 97.87% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.10. ALVO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 49.07
Fwd PE 8.26
ALVO Price Earnings VS Forward Price EarningsALVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALVO is valued cheaper than 92.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.84
ALVO Per share dataALVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALVO's earnings are expected to grow with 222.21% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y222.21%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALVO Dividend Analysis

5.1 Amount

  • No dividends for ALVO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALVO Fundamentals: All Metrics, Ratios and Statistics

ALVOTECH SA

NASDAQ:ALVO (3/31/2026, 1:55:34 PM)

3.435

+0.15 (+4.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-18
Earnings (Next)05-06
Inst Owners5.39%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap1.07B
Revenue(TTM)588.90M
Net Income(TTM)27.92M
Analysts78.33
Price Target8.08 (135.23%)
Short Float %2.13%
Short Ratio4.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-425.6%
Min EPS beat(2)-706.1%
Max EPS beat(2)-145.1%
EPS beat(4)2
Avg EPS beat(4)29.57%
Min EPS beat(4)-706.1%
Max EPS beat(4)557.52%
EPS beat(8)5
Avg EPS beat(8)1035.23%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-4.76%
Max Revenue beat(2)3.53%
Revenue beat(4)3
Avg Revenue beat(4)19.21%
Min Revenue beat(4)-4.76%
Max Revenue beat(4)41.02%
Revenue beat(8)5
Avg Revenue beat(8)12.37%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.52%
PT rev (3m)-9.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)4.69%
Revenue NQ rev (3m)4.69%
Revenue NY rev (1m)-5.52%
Revenue NY rev (3m)-5.52%
Valuation
Industry RankSector Rank
PE 49.07
Fwd PE 8.26
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 19.84
EPS(TTM)0.07
EY2.04%
EPS(NY)0.42
Fwd EY12.1%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS1.89
BVpS-0.91
TBVpS-1.22
PEG (NY)0.1
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.88%
ROE N/A
ROCE 6.61%
ROIC 5.22%
ROICexc 6.11%
ROICexgc 6.74%
OM 13.28%
PM (TTM) 4.74%
GM 60%
FCFM N/A
ROA(3y)-25.06%
ROA(5y)-30.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y34.59%
GM growth 5YN/A
F-Score2
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 12.06
Cap/Depr 253.97%
Cap/Sales 16.32%
Interest Coverage 1.33
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.89
Quick Ratio 1.16
Altman-Z -1.12
F-Score2
WACC6.03%
ROIC/WACC0.87
Cap/Depr(3y)209.34%
Cap/Depr(5y)218.29%
Cap/Sales(3y)25.89%
Cap/Sales(5y)47.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.17%
EPS Next Y493.79%
EPS Next 2Y222.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.7%
Revenue growth 3Y90.62%
Revenue growth 5Y53.35%
Sales Q2Q%10.14%
Revenue Next Year37.22%
Revenue Next 2Y31.38%
Revenue Next 3YN/A
Revenue Next 5Y25.37%
EBIT growth 1Y12.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year153.92%
EBIT Next 3YN/A
EBIT Next 5Y49.94%
FCF growth 1Y50.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.81%
OCF growth 3YN/A
OCF growth 5YN/A

ALVOTECH SA / ALVO Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ALVOTECH SA (ALVO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALVO.


What is the valuation status of ALVOTECH SA (ALVO) stock?

ChartMill assigns a valuation rating of 6 / 10 to ALVOTECH SA (ALVO). This can be considered as Fairly Valued.


Can you provide the profitability details for ALVOTECH SA?

ALVOTECH SA (ALVO) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for ALVO stock?

The Earnings per Share (EPS) of ALVOTECH SA (ALVO) is expected to grow by 493.79% in the next year.